Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV.
Identifieur interne : 002C41 ( PubMed/Checkpoint ); précédent : 002C40; suivant : 002C42Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV.
Auteurs : Miriam E R. Darnell [États-Unis] ; Kanta Subbarao ; Stephen M. Feinstone ; Deborah R. TaylorSource :
- Journal of virological methods [ 0166-0934 ] ; 2004.
Descripteurs français
- KwdFr :
- Animaux, Antiviraux (pharmacologie), Cellules Vero, Cinétique, Concentration en ions d'hydrogène, Facteurs temps, Formaldéhyde (pharmacologie), Glutaraldéhyde (pharmacologie), Inactivation virale, Rayons ultraviolets, Température élevée, Virus du SRAS (), Virus du SRAS (effets des radiations), Virus du SRAS (physiologie).
- MESH :
- effets des radiations : Virus du SRAS.
- pharmacologie : Antiviraux, Formaldéhyde, Glutaraldéhyde.
- physiologie : Virus du SRAS.
- Animaux, Cellules Vero, Cinétique, Concentration en ions d'hydrogène, Facteurs temps, Inactivation virale, Rayons ultraviolets, Température élevée, Virus du SRAS.
English descriptors
- KwdEn :
- Animals, Antiviral Agents (pharmacology), Chlorocebus aethiops, Formaldehyde (pharmacology), Glutaral (pharmacology), Hot Temperature, Hydrogen-Ion Concentration, Kinetics, SARS Virus (drug effects), SARS Virus (physiology), SARS Virus (radiation effects), Time Factors, Ultraviolet Rays, Vero Cells, Virus Inactivation.
- MESH :
- chemical , pharmacology : Antiviral Agents, Formaldehyde, Glutaral.
- drug effects : SARS Virus.
- physiology : SARS Virus.
- radiation effects : SARS Virus.
- Animals, Chlorocebus aethiops, Hot Temperature, Hydrogen-Ion Concentration, Kinetics, Time Factors, Ultraviolet Rays, Vero Cells, Virus Inactivation.
Abstract
Severe acute respiratory syndrome (SARS) is a life-threatening disease caused by a novel coronavirus termed SARS-CoV. Due to the severity of this disease, the World Health Organization (WHO) recommends that manipulation of active viral cultures of SARS-CoV be performed in containment laboratories at biosafety level 3 (BSL3). The virus was inactivated by ultraviolet light (UV) at 254 nm, heat treatment of 65 degrees C or greater, alkaline (pH > 12) or acidic (pH < 3) conditions, formalin and glutaraldehyde treatments. We describe the kinetics of these efficient viral inactivation methods, which will allow research with SARS-CoV containing materials, that are rendered non-infectious, to be conducted at reduced safety levels.
DOI: 10.1016/j.jviromet.2004.06.006
PubMed: 15350737
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:15350737Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV.</title><author><name sortKey="Darnell, Miriam E R" sort="Darnell, Miriam E R" uniqKey="Darnell M" first="Miriam E R" last="Darnell">Miriam E R. Darnell</name><affiliation wicri:level="2"><nlm:affiliation>Center for Biologics Evaluation and Research, US Food and Drug Administration, 8800 Rockville Pike, HFM448, Bethesda, MD 20892, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Biologics Evaluation and Research, US Food and Drug Administration, 8800 Rockville Pike, HFM448, Bethesda, MD 20892</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Subbarao, Kanta" sort="Subbarao, Kanta" uniqKey="Subbarao K" first="Kanta" last="Subbarao">Kanta Subbarao</name></author><author><name sortKey="Feinstone, Stephen M" sort="Feinstone, Stephen M" uniqKey="Feinstone S" first="Stephen M" last="Feinstone">Stephen M. Feinstone</name></author><author><name sortKey="Taylor, Deborah R" sort="Taylor, Deborah R" uniqKey="Taylor D" first="Deborah R" last="Taylor">Deborah R. Taylor</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15350737</idno><idno type="pmid">15350737</idno><idno type="doi">10.1016/j.jviromet.2004.06.006</idno><idno type="wicri:Area/PubMed/Corpus">002B77</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B77</idno><idno type="wicri:Area/PubMed/Curation">002B77</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002B77</idno><idno type="wicri:Area/PubMed/Checkpoint">002C41</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002C41</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV.</title><author><name sortKey="Darnell, Miriam E R" sort="Darnell, Miriam E R" uniqKey="Darnell M" first="Miriam E R" last="Darnell">Miriam E R. Darnell</name><affiliation wicri:level="2"><nlm:affiliation>Center for Biologics Evaluation and Research, US Food and Drug Administration, 8800 Rockville Pike, HFM448, Bethesda, MD 20892, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Biologics Evaluation and Research, US Food and Drug Administration, 8800 Rockville Pike, HFM448, Bethesda, MD 20892</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Subbarao, Kanta" sort="Subbarao, Kanta" uniqKey="Subbarao K" first="Kanta" last="Subbarao">Kanta Subbarao</name></author><author><name sortKey="Feinstone, Stephen M" sort="Feinstone, Stephen M" uniqKey="Feinstone S" first="Stephen M" last="Feinstone">Stephen M. Feinstone</name></author><author><name sortKey="Taylor, Deborah R" sort="Taylor, Deborah R" uniqKey="Taylor D" first="Deborah R" last="Taylor">Deborah R. Taylor</name></author></analytic><series><title level="j">Journal of virological methods</title><idno type="ISSN">0166-0934</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antiviral Agents (pharmacology)</term><term>Chlorocebus aethiops</term><term>Formaldehyde (pharmacology)</term><term>Glutaral (pharmacology)</term><term>Hot Temperature</term><term>Hydrogen-Ion Concentration</term><term>Kinetics</term><term>SARS Virus (drug effects)</term><term>SARS Virus (physiology)</term><term>SARS Virus (radiation effects)</term><term>Time Factors</term><term>Ultraviolet Rays</term><term>Vero Cells</term><term>Virus Inactivation</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Antiviraux (pharmacologie)</term><term>Cellules Vero</term><term>Cinétique</term><term>Concentration en ions d'hydrogène</term><term>Facteurs temps</term><term>Formaldéhyde (pharmacologie)</term><term>Glutaraldéhyde (pharmacologie)</term><term>Inactivation virale</term><term>Rayons ultraviolets</term><term>Température élevée</term><term>Virus du SRAS ()</term><term>Virus du SRAS (effets des radiations)</term><term>Virus du SRAS (physiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term><term>Formaldehyde</term><term>Glutaral</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="effets des radiations" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antiviraux</term><term>Formaldéhyde</term><term>Glutaraldéhyde</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="radiation effects" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Chlorocebus aethiops</term><term>Hot Temperature</term><term>Hydrogen-Ion Concentration</term><term>Kinetics</term><term>Time Factors</term><term>Ultraviolet Rays</term><term>Vero Cells</term><term>Virus Inactivation</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Cellules Vero</term><term>Cinétique</term><term>Concentration en ions d'hydrogène</term><term>Facteurs temps</term><term>Inactivation virale</term><term>Rayons ultraviolets</term><term>Température élevée</term><term>Virus du SRAS</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) is a life-threatening disease caused by a novel coronavirus termed SARS-CoV. Due to the severity of this disease, the World Health Organization (WHO) recommends that manipulation of active viral cultures of SARS-CoV be performed in containment laboratories at biosafety level 3 (BSL3). The virus was inactivated by ultraviolet light (UV) at 254 nm, heat treatment of 65 degrees C or greater, alkaline (pH > 12) or acidic (pH < 3) conditions, formalin and glutaraldehyde treatments. We describe the kinetics of these efficient viral inactivation methods, which will allow research with SARS-CoV containing materials, that are rendered non-infectious, to be conducted at reduced safety levels.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15350737</PMID><DateCompleted><Year>2005</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0166-0934</ISSN><JournalIssue CitedMedium="Print"><Volume>121</Volume><Issue>1</Issue><PubDate><Year>2004</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of virological methods</Title><ISOAbbreviation>J. Virol. Methods</ISOAbbreviation></Journal><ArticleTitle>Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV.</ArticleTitle><Pagination><MedlinePgn>85-91</MedlinePgn></Pagination><Abstract><AbstractText>Severe acute respiratory syndrome (SARS) is a life-threatening disease caused by a novel coronavirus termed SARS-CoV. Due to the severity of this disease, the World Health Organization (WHO) recommends that manipulation of active viral cultures of SARS-CoV be performed in containment laboratories at biosafety level 3 (BSL3). The virus was inactivated by ultraviolet light (UV) at 254 nm, heat treatment of 65 degrees C or greater, alkaline (pH > 12) or acidic (pH < 3) conditions, formalin and glutaraldehyde treatments. We describe the kinetics of these efficient viral inactivation methods, which will allow research with SARS-CoV containing materials, that are rendered non-infectious, to be conducted at reduced safety levels.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Darnell</LastName><ForeName>Miriam E R</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Center for Biologics Evaluation and Research, US Food and Drug Administration, 8800 Rockville Pike, HFM448, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subbarao</LastName><ForeName>Kanta</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Feinstone</LastName><ForeName>Stephen M</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Deborah R</ForeName><Initials>DR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Virol Methods</MedlineTA><NlmUniqueID>8005839</NlmUniqueID><ISSNLinking>0166-0934</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>1HG84L3525</RegistryNumber><NameOfSubstance UI="D005557">Formaldehyde</NameOfSubstance></Chemical><Chemical><RegistryNumber>T3C89M417N</RegistryNumber><NameOfSubstance UI="D005976">Glutaral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005557" MajorTopicYN="N">Formaldehyde</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005976" MajorTopicYN="N">Glutaral</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006358" MajorTopicYN="N">Hot Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName><QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014466" MajorTopicYN="N">Ultraviolet Rays</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038301" MajorTopicYN="Y">Virus Inactivation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>05</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2004</Year><Month>06</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>9</Month><Day>8</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>2</Month><Day>9</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>9</Month><Day>8</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15350737</ArticleId><ArticleId IdType="doi">10.1016/j.jviromet.2004.06.006</ArticleId><ArticleId IdType="pii">S0166-0934(04)00179-X</ArticleId><ArticleId IdType="pmc">PMC7112912</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Transfusion. 2001 Mar;41(3):382-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11274595</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1990 Jun;64(6):3051-5</Citation><ArticleIdList><ArticleId IdType="pubmed">1692350</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biologicals. 2002 Jun;30(2):125-33</Citation><ArticleIdList><ArticleId IdType="pubmed">12127314</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2004 Apr 30;304(5671):659-61</Citation><ArticleIdList><ArticleId IdType="pubmed">15118129</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Vaccine. 1984 Mar;2(1):59-74</Citation><ArticleIdList><ArticleId IdType="pubmed">6099644</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Med Virol. 1987 Nov;23(3):297-301</Citation><ArticleIdList><ArticleId IdType="pubmed">2828525</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Gastroenterology. 2003 Oct;125(4):1011-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14517783</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Epidemiol. 1969 Apr;89(4):422-34</Citation><ArticleIdList><ArticleId IdType="pubmed">4305198</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biomed Environ Sci. 2003 Sep;16(3):246-55</Citation><ArticleIdList><ArticleId IdType="pubmed">14631830</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Microbiol Rev. 1999 Jan;12(1):147-79</Citation><ArticleIdList><ArticleId IdType="pubmed">9880479</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biologicals. 2002 Sep;30(3):207-16</Citation><ArticleIdList><ArticleId IdType="pubmed">12217345</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation><ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Photochem Photobiol B. 2001 Oct;63(1-3):88-102</Citation><ArticleIdList><ArticleId IdType="pubmed">11684456</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Gen Virol. 1981 Oct;56(Pt 2):235-40</Citation><ArticleIdList><ArticleId IdType="pubmed">6273497</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biotechnol Bioeng. 2000 Dec 5;70(5):507-17</Citation><ArticleIdList><ArticleId IdType="pubmed">11042547</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2003 Dec 26;312(4):1159-64</Citation><ArticleIdList><ArticleId IdType="pubmed">14651994</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>JAMA. 1967 Dec 18;202(12):1075-80</Citation><ArticleIdList><ArticleId IdType="pubmed">6072745</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Gastroenterol Hepatol. 2000 Oct;15 Suppl:G69-72</Citation><ArticleIdList><ArticleId IdType="pubmed">11100996</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Biol Chem. 2000 Sep 1;275(35):26732-42</Citation><ArticleIdList><ArticleId IdType="pubmed">10827179</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Biochim Biophys Acta. 1954 Oct;15(2):307-9</Citation><ArticleIdList><ArticleId IdType="pubmed">13208707</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Maryland</li></region></list><tree><noCountry><name sortKey="Feinstone, Stephen M" sort="Feinstone, Stephen M" uniqKey="Feinstone S" first="Stephen M" last="Feinstone">Stephen M. Feinstone</name><name sortKey="Subbarao, Kanta" sort="Subbarao, Kanta" uniqKey="Subbarao K" first="Kanta" last="Subbarao">Kanta Subbarao</name><name sortKey="Taylor, Deborah R" sort="Taylor, Deborah R" uniqKey="Taylor D" first="Deborah R" last="Taylor">Deborah R. Taylor</name></noCountry><country name="États-Unis"><region name="Maryland"><name sortKey="Darnell, Miriam E R" sort="Darnell, Miriam E R" uniqKey="Darnell M" first="Miriam E R" last="Darnell">Miriam E R. Darnell</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C41 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002C41 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:15350737
|texte= Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:15350737" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |